Related Experiment Video

Updated: Jun 24, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

[Developmental causes in variability of efficacy and toxicity of analgesics in pediatrics]

M Diezi1

  • 1Unite d'hémato-oncologie pédiatrique, Département médico-chirurgical de pédiatrie, CHUV, 1011 Lausanne.

Revue Medicale Suisse
|April 1, 2009
PubMed

Insights

Pain perception and drug response vary significantly between individuals. Understanding developmental changes in drug disposition is crucial for safe and effective pediatric pain management, preventing ineffective or toxic treatments.

Area of Science:

  • Pharmacology
  • Pediatrics
  • Pain Management

Context:

  • Individual variability in pain perception and analgesic drug response is a significant clinical challenge.
  • Drug disposition (absorption, distribution, metabolism, excretion) undergoes substantial changes during physiological development.
  • These developmental pharmacokinetic and pharmacodynamic shifts are not fully elucidated but impact treatment outcomes.

Purpose:

  • To highlight the importance of considering developmental changes in drug disposition for pediatric patients.
  • To underscore the variability in drug effects and the risks of suboptimal treatment.
  • To emphasize the need for individualized approaches in pediatric pharmacotherapy.

Summary:

  • Pain perception and response to analgesics differ greatly among individuals.
  • Physiological maturation during development alters how the body processes drugs.
  • These developmental factors are critical for safe and effective pediatric pain management, requiring careful consideration of age, drug type, disease, and co-administered substances.

Impact:

  • Informing clinical practice for safer and more effective pain management in children.
  • Reducing risks of adverse drug events and treatment failure in pediatric populations.
  • Guiding future research into pediatric drug disposition and personalized pharmacotherapy.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...